PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials ...

PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today the launch of its new webinar series exploring the latest innovations in ...

Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...

Newronika announced today that it closed a €13.6 million ($14.1 million) Series B round to support its deep brain stimulation ...

Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...

PhaseV's Adaptive Clinical Trials Platform Will Support the Gastrointestinal CRO in Addressing a Wide Range of GI-Related Conditions The collaboration has the potential to accelerate the ...

For people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials targeting gastrointestinal (GI) conditions. This collaboration ...